Biopharma Stock Soaring on Buyout News

Options traders are targeting AVEO at 17 times the intraday average volume

Laura McCandless

Deputy Editor

Oct 18, 2022 at 3:14 PM

Aveo Pharmaceuticals Inc (NASDAQ:AVEO) stock is soaring today, up 40.7% at $14.74 at last glance, after news that South Korean chemical company LG Chem plans to buy the biopharmaceutical name for $15 per share, or roughly $566 million, in an all-cash deal. The acquisition will expand LG's U.S. presence and propel it further into cancer development.

This bull gap has AVEO at its highest level since March of 2021. The stock was already moving higher before today's bull gap, though, thanks to its 60-day moving average. Year-to-date, the equity is up 215.6%. A short-term drop could be overdue, however, as AVEO's 14-day relative strength index (RSI) of 83.5 sits firmly in "overbought" territory.

AVEO's options pits are teeming with activity amid the news. So far, 8,145 calls and 1,165 puts have crossed the tape -- 17 times the volume typically seen at this point. The January 2023 15-strike call is the most popular, followed by the October 15 call, with new positions being opened at both.

Follow @Schaeffers

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.